T. Rowe Price Investment Management
EXAS

T. Rowe Price Investment Management’s Exact Sciences EXAS Stock Holding History

T. Rowe Price Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-190
Closed -$20K – 745
2025
Q4 		$20K Sell
190
-106,489
-100% -$8.55M ﹤0.01% 684
2025
Q3 		$5.84M Sell
106,679
-215,727
-67% -$10.8M ﹤0.01% 572
2025
Q2 		$17.1M Sell
322,406
-2,596,623
-89% -$132M 0.01% 518
2025
Q1 		$126M Sell
2,919,029
-1,350,794
-32% -$68.4M 0.08% 234
2024
Q4 		$240M Buy
4,269,823
+876,985
+26% +$54.6M 0.15% 154
2024
Q3 		$231M Buy
3,392,838
+451,636
+15% +$25.5M 0.14% 166
2024
Q2 		$124M Buy
2,941,202
+2,700
+0.1% +$149K 0.08% 244
2024
Q1 		$203M Sell
2,938,502
-12,800
-0.4% -$810K 0.12% 186
2023
Q4 		$218M Sell
2,951,302
-1,300
-0% -$85.2K 0.14% 172
2023
Q3 		$201M Sell
2,952,602
-8,244
-0.3% -$699K 0.14% 176
2023
Q2 		$278M Buy
2,960,846
+23,272
+0.8% +$1.82M 0.19% 132
2023
Q1 		$199M Buy
2,937,574
+2,283
+0.1% +$147K 0.14% 161
2022
Q4 		$145M Sell
2,935,291
-2,593
-0.1% -$106K 0.11% 194
2022
Q3 		$95.5M Buy
+2,937,884
New +$121M 0.08% 249

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

T. Rowe Price Investment Management's EXAS Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 190 shares — an estimated $20K sold.

T. Rowe Price Investment Management first reported a position in EXAS in Q3 2022 and held it in 14 quarters. The position peaked at $278M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 190 Exact Sciences shares in Q1 2026, an estimated $20K.
  • T. Rowe Price Investment Management first reported a position in Exact Sciences in Q3 2022 and held it in 14 quarters.
  • T. Rowe Price Investment Management's Exact Sciences position peaked at $278M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.